Cohort I (n = 100) | Cohort II (n = 342) | |||||
---|---|---|---|---|---|---|
Factor | n (%) | Ezrin expression | n (%) | Ezrin expression | ||
median (range) | p-value | median (range) | p-value | |||
Age | ||||||
≤ average | 46 (46.9) | 30.9 (0.0-100) | 0.222 | 157 (45.9) | 10.0 (0.0-100) | 0.136 |
>average | 54 (54.0) | 35.0 (0.0-95.0) | 185 (54.1) | 10.0 (0.0-100) | ||
Gender | ||||||
Female | 25 (25.9) | 10.0 (0.0-90.0) | 0.040 | 82 (24.0) | 5.00 (0.0-90.0) | 0.013 |
Male | 75 (75.0) | 40.0 (0.0-100) | 260 (76.0) | 10.0 (0.0-100) | ||
T-stage | ||||||
Ta | 41 (41.0) | 75.0 (0.0-100) | <0.001 | 115 (33.6) | 30.0 (0.0-100) | <0.001 |
T1 | 22 (22.0) | 25.0 (0.0-95.0) | 116 (33.9) | 10.0 (0.0-95.0) | ||
T2-3 | 37 (37.0) | 2.0 (0.0-80.0) | 111 (32.5) | 0.0 (0.0-60.0) | ||
Grade | ||||||
Low | 44 (44.0) | 72.5 (0.0-100) | <0.001 | 82 (24.0) | 40.0 (0.0-100) | <0.001 |
High | 56 (56.0) | 10.0 (0.0-90.0) | 260 (76.0) | 5.0 (0.0-95.0) | ||
PODXL expression | ||||||
Negative | 78 (78.8) | 40.0 (0.0-100) | <0.001 | 306 (89.7) | 10.0 (0.0-100) | 0.009 |
Positive | 21 (21.0) | 5.00 (0–70.0) | 35 (10.2) | (0.0-0.80) |